Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 275 No 7360 p430
8 October 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Scottish prescription volume and cost rise

More NHS prescriptions than ever are being dispensed in the community in Scotland, according to statistics published this week. In addition, the cost of prescriptions continues to rise.

The data — prescribing statistics for the year 2004–05 — show that the cost of NHS prescriptions dispensed by community pharmacists, dispensing doctors and appliance suppliers was £859m, up 2 per cent on the previous year. Drugs used to treat mental illness, respiratory disease and conditions affecting the endocrine system had the largest impact on rising costs. Meanwhile, the cost of drugs used in gastrointestinal and cardiovascular diseases fell, not least because of the impact of simvastatin coming off patent.

The top 10 drugs dispensed by volume were (in order): aspirin, bendroflumethiazide, atenolol, co-codamol, salbutamol, simvastatin, levothyroxine, amoxicillin, omeprazole and lansoprazole.

This compares with the top 10 drugs by cost, which were (in order): lansoprazole, atorvastatin, simvastatin, omeprazole, salmeterol, amlodipine, clopidogrel, venlafaxine and pravastatin.

Total prescription volume in 2004–05 was 74.7 million items, a rise of 3.5 per cent compared with the previous year. This compares with 40.1 million items in 1987–88. Generic prescribing also increased by just over 1 per cent: 80.1 per cent of prescriptions were written generically last year.

Back to Top


©The Pharmaceutical Journal